Showing results (2201-2210 of 30,686) with videos related to

Sort By:
Pageof 3,069
Frontiers in Pharmacology|November 10, 2016
Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability InterplayAvital Beig, David Lindley, Jonathan M Miller, et al.
Frontiers in Pharmacology|November 10, 2016
Genetic Ablation of CXCR2 Protects against Cigarette Smoke-Induced Lung Inflammation and InjuryChad A Lerner, Wei Lei, Isaac K Sundar, et al.
Frontiers in Pharmacology|November 10, 2016
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesPei Shi Ong, Louis Z Wang, Xiaoyun Dai, et al.
Frontiers in Pharmacology|December 21, 2016
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 CellsFeifei Wu, Li Zhou, Wangdong Jin, et al.
Frontiers in Pharmacology|December 21, 2016
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer PropertiesZhijie Xu, Yuanliang Yan, Zhi Li, et al.
Frontiers in Pharmacology|December 20, 2016
Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association StudiesMiles D Thompson, Valerie Capra, Mark T Clunes, et al.
Frontiers in Pharmacology|December 20, 2016
Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain TraumaBrian DellaValle, Gitte S Brix, Birgitte Brock, et al.
Frontiers in Pharmacology|December 24, 2016
Chrysophanic Acid Suppresses Adipogenesis and Induces Thermogenesis by Activating AMP-Activated Protein Kinase Alpha In vivo and In vitroHara Lim, Jinbong Park, Hye-Lin Kim, et al.
Frontiers in Pharmacology|January 14, 2017
Comparison of Different Risk Classification Systems in 558 Patients with Gastrointestinal Stromal Tumors after R0-ResectionMichael Schmieder, Doris Henne-Bruns, Benjamin Mayer, et al.
Frontiers in Pharmacology|January 14, 2017
Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical SituationsHiroshi Miyata, Tappei Takada, Yu Toyoda, et al.
Pageof 3,069